Matt Tremblay

Matt Tremblay, Ph.D., holds a Doctor of Philosophy in Chemistry from Columbia University. Currently, Matt serves as the Chief Executive Officer at Blackbird Laboratories and as the Board Chair at AIM-HI Accelerator Fund. In the past, Matt has held various leadership roles, including Chief Operating Officer at Scripps Research and California Institute for Biomedical Research, as well as a Research Investigator II at GNF. Matt's experience also includes being a Postdoctoral Fellow at The Scripps Research Institute and a Graduate Researcher at Columbia University. Currently, Matt is also a part of the Steering Board at Eshelman Institute for Innovation at UNC Eshelman School of Pharmacy.